Cerebrospinal fluid from Alzheimer’s disease patients as an optimal formulation for therapeutic application of mesenchymal stem cells in Alzheimer’s disease

Mesenchymal stem cells (MSCs) have emerged as one of the promising treatment options for Alzheimer’s disease (AD). Although many studies have investigated on the efficacy of MSCs in AD, how MSCs actually change following exposure to the AD environment has not been studied extensively. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jeongmin, Kwon, Soo Jin, Kim, Jang Hoon, Jang, Hyemin, Lee, Na Kyung, Hwang, Jung Won, Kim, Jong Hwa, Chang, Jong Wook, Na, Duk L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346116/
https://www.ncbi.nlm.nih.gov/pubmed/30679696
http://dx.doi.org/10.1038/s41598-018-37252-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346116/
https://www.ncbi.nlm.nih.gov/pubmed/30679696
http://dx.doi.org/10.1038/s41598-018-37252-9

Ejemplares similares